Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE

被引：0
|
作者：
Yue Yang
Xing-Fu Li
Xiao Zhang
Chun-De Bao
Jian-Kang Hu
Jian-Hua Xu
Xiang-Pei Li
Jian Xu
Dong-Yi He
Zhi-Jun Li
Guo-Chun Wang
Han-Jun Wu
Fei Ji
Lu-Jing Zhan
Cristiano A. F. Zerbini
Zhan-Guo Li
机构：
[1] Peking University People’s Hospital,
[2] Qilu Hospital of Shandong University,undefined
[3] Guangdong General Hospital,undefined
[4] Renji Hospital Shanghai Jiaotong University School of Medicine,undefined
[5] Jiangxi Pingxiang People’s Hospital,undefined
[6] The First Affiliated Hospital of Anhui Medical University,undefined
[7] The First Affiliated Hospital of USTC (Anhui Provincial Hospital),undefined
[8] Division of Life Sciences and Medicine,undefined
[9] University of Science and Technology of China,undefined
[10] First Affiliated Hospital of Kunming Medical University,undefined
[11] GuangHua Hospital,undefined
[12] First Affiliated Hospital of Bengbu Medical College,undefined
[13] China-Japan Friendship Hospital,undefined
[14] Eli Lilly and Company,undefined
[15] CEPIC-Centro Paulista de Investigação Clinica E Serviços Medicos,undefined
[16] Ipiranga,undefined
来源：
Rheumatology and Therapy | 2020年 / 7卷
关键词：
Arthritis; Baricitinib; China; Rheumatoid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：851 / 866
页数：15
相关论文
共 50 条
  • [21] Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2)
    Takeuchi, Tsutomu
    Matsubara, Tsukasa
    Atsumi, Tatsuya
    Amano, Koichi
    Ishiguro, Naoki
    Sugiyama, Eiji
    Yamaoka, Kunihiro
    Genovese, Mark C.
    Kalunian, Kenneth
    Walker, David
    Gottenberg, Jacques-Eric
    de Vlam, Kurt
    Bartok, Beatrix
    Pechonkina, Alena
    Kondo, Akira
    Gao, Jie
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2022, 32 (01) : 59 - 67
  • [22] Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study
    Pal, Sarvajeet
    Veeravalli, Sarath Chandra Mouli
    Das, Siddharth Kumar
    Shobha, Vineeta
    Uppuluri, Ramakrishna Rao
    Dharmanand, B. G.
    Nadkar, Milind
    Hsia, Elizabeth
    Fei, Kaiyin
    Yao, Ruji
    Khalifa, Ahmed
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (11) : 1083 - 1092
  • [23] Baricitinib Improves Bone Biomechanical Properties in Rheumatoid Arthritis (RA) - Results of a Prospective Interventional Study
    Kemenes, Stephan
    Tascilar, Koray
    Simon, David
    Bayat, Sara
    Kroenke, Gerhard
    Mendez, Larissa Valor
    Hartmann, Fabian
    Schuster, Louis
    Liphardt, Anna-Maria
    Schett, Georg
    Kleyer, Arnd
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3931 - 3933
  • [24] EFFICACY AND SAFETY OF LEFLUNOMIDE IN THE TREATMENT OF PATIENTS WITH RHEUMATOID-ARTHRITIS (RA)
    DOMLJAN, Z
    POPOVIC, M
    MIADENOVIC, V
    ROZMAN, B
    MIHAJLOVIC, D
    JAJIC, I
    ZIVKOVIC, M
    STRAND, V
    LOWFRIEDRICH, I
    OED, C
    MUSIKIC, P
    SEIFERT, H
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S56 - S56
  • [25] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS: SUMMARY RESULTS FROM THE 24-WEEK PHASE III RA-BEACON STUDY
    Zamani, Omid
    Combe, Bernard
    Tony, Hans-Peter
    Sanchez Burson, Juan
    Tahir, Hasan
    Ostergaard, Mikkel
    Augendre-Ferrante, Beatrice
    Beselin, Anke
    Larsson, Esbjorn
    Casillas, Marta
    Smolen, Josef
    RHEUMATOLOGY, 2016, 55 : 93 - 93
  • [26] EFFICACY AND SAFETY OF BARICITINIB AND TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM REAL-WORLD
    Gonzalez Mazario, R.
    Fragio-Gil, J. J.
    Grau Garcia, E.
    De la Rubia Navarro, M.
    Pavez Perales, C.
    Leal Rodriguez, S.
    Ivorra Cortes, J.
    Negueroles Albuixech, R.
    Gonzalez Puig, L.
    Oller Rodriguez, J. E.
    Alcaniz Escandell, C.
    Vicens Bernabeu, E.
    Chalmeta Verdejo, I.
    Martinez Cordellat, I.
    Ortiz Sanjuan, F. M.
    Najera Herranz, C.
    Canovas Olmos, I.
    Canada Martinez, A. J.
    Roman Ivorra, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 639 - 640
  • [27] Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors: 24-week phase 3 RA-BEACON study results
    Zamani, O.
    Combe, B.
    Tony, H. P.
    Sanchez Burson, J.
    Tahir, H.
    Ostergaard, M.
    Augendre-Ferrante, B.
    Beselin, A.
    Larsson, E.
    Casillas, M.
    Smolen, J.
    SWISS MEDICAL WEEKLY, 2016, 146 : 3S - 3S
  • [28] Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study
    Li, Z.
    Hu, J.
    Bao, C.
    Li, X.
    Li, X.
    Xu, J.
    Spindler, A. J.
    Zhang, X.
    Xu, J.
    He, D.
    Li, Z.
    Wang, G.
    Yang, Y.
    Wu, H.
    Ji, F.
    Tao, H.
    Zhan, L.
    Bai, F.
    Rooney, T. P.
    Zerbini, C. A. F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) : 732 - 741
  • [29] Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study
    Maeyama, Akira
    Kondo, Masakazu
    Harada, Hiroshi
    Shono, Eisuke
    Nagamine, Ryuji
    Tsuru, Tomomi
    Inoue, Yasushi
    Nakashima, Munetoshi
    Yamasaki, Yutaro
    Niiro, Hiroaki
    Nakashima, Yasuharu
    Yamamoto, Takuaki
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [30] PAIN IMPROVEMENT IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BARICITINIB: RESULTS OF A PROSPECTIVE STUDY
    Gil Velez, Ricardo Juan
    Aguilera Cros, Clara
    Ruiz Roman, Alberto
    Mendez Diaz, Lara
    Alonso Morales, Elena
    Rubio Romero, Esteban
    Povedano Gomez, Juan
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1620 - 1620
12345